Clinical Trials Directory

Trials / Unknown

UnknownNCT05582603

Safety and Dosage of a Computerized Cognitive Training Program for Cognitive Dysfunction After COVID-19

Detailed Study on the Safety, Dosage and Feasibility of an Intervention Based on a Computerized Cognitive Training (CCT) for Individuals With Post-acute Sequelae of COVID-19 (PASC): A Phase I/II Trial

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Universidad Antonio de Nebrija · Academic / Other
Sex
All
Age
25 Years – 55 Years
Healthy volunteers
Accepted

Summary

The goal of this Phase I/II clinical trial is to assess the safety and maximum tolerated training time of a self-administered computerized cognitive training (CCT) in individuals with cognitive dysfunction as a consequence of COVID-19 infection.

Detailed description

A Phase I/II protocol is designed to determine the safety of a Computerized Cognitive Training (CCT) aimed at ameliorating the cognitive dysfunction often observed in persons with post-acute sequelae of COVID-19 (PASC). The Phase I/II trial also aims at establishing the maximum tolerated training time per session of the CCT and to explore the feasibility of such intervention. In Phase I, through a 3+3 design, a dose-escalation trial will be set. Participants will be tested across subsequent training blocks of 15 minutes each, reporting on the experienced fatigue or adverse effects after every block. The safe training dose will be set to a block before extreme fatigue or a notable adverse effect has been reported by two or more participants. Once a safety training time has been established, a group of participants will engage in a 15-day training effectiveness assessment. After an initial thorough pre-test assessment, the intervention protocol will start. An evaluation day and a training day will be interspersed so that participants will complete a total of 8 training sessions (days 1, 3, 5, 7, 9, 11, 13 and 15). After the final day of intervention, a post-test assessment session will be carried out.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCCT Long COVIDA 15-day training protocol in which every 48 hours participants' complete a series of different cognitive tasks in the form of games selected among a pool of 12 games from CogniFit (CogniFit Inc., San Francisco, USA) whose difficulty level is tailored to each individual by the a patented Individualized Training System™ (ITS) software that automatically chooses the activities and difficulty levels for each person in every session.

Timeline

Start date
2022-10-18
Primary completion
2022-11-30
Completion
2022-11-30
First posted
2022-10-17
Last updated
2022-10-18

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05582603. Inclusion in this directory is not an endorsement.